IL6 and asbestosis: IL-6 and its secreted receptor sIL-6Rα are increasingly recognized as master cytokines (40, 41), upstream of a wide array of inflammatory processes, including pathologies as diverse as cytokine release syndrome (42), acute allograft rejection (43), rheumatoid arthritis (44), asbestosis (45) and cachexia (46).